BR9813279B1 - derivado de homopiperazina, composição farmacêutica, e, uso do derivado de homopiperazina. - Google Patents

derivado de homopiperazina, composição farmacêutica, e, uso do derivado de homopiperazina.

Info

Publication number: BR9813279B1
Authority: BR; Brazil
Prior art keywords: alkyl; alkoxy; cycloalkylalkyl; cycloalkyl; alkynoxy
Prior art date: 1997-10-27

Application number

BRPI9813279-2A

Other languages

English (en)

Other versions

BR9813279A (pt

Inventor

Gunnar M Olsen

Simon Feldbaek Nielsen

Elsebet Ostergaard Nielsen

Dan Peters

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-10-27

Filing date

1998-10-27

Publication date

2010-11-16

1998-10-27 Application filed filed Critical

2000-08-22 Publication of BR9813279A publication Critical patent/BR9813279A/pt

2010-11-16 Publication of BR9813279B1 publication Critical patent/BR9813279B1/pt

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/06—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
- C07D213/22—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom containing two or more pyridine rings directly linked together, e.g. bipyridyl
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/08—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 not condensed with other rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Pain & Pain Management (AREA)
Pulmonology (AREA)
Psychology (AREA)
Psychiatry (AREA)
Hospice & Palliative Care (AREA)
Orthopedic Medicine & Surgery (AREA)
Urology & Nephrology (AREA)
Addiction (AREA)
Vascular Medicine (AREA)
Rheumatology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Pyridine Compounds (AREA)
Other In-Based Heterocyclic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

BRPI9813279-2A 1997-10-27 1998-10-27 derivado de homopiperazina, composição farmacêutica, e, uso do derivado de homopiperazina. BR9813279B1 (pt)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
DK122597		1997-10-27
DK40998		1998-03-24
DK79698		1998-06-19
PCT/DK1998/000465 WO1999021834A1 (en)	1997-10-27	1998-10-27	Heteroaryl diazacycloalkanes as cholinergic ligands at nicotinic acetylcholine receptors

Publications (2)

Publication Number	Publication Date
BR9813279A BR9813279A (pt)	2000-08-22
BR9813279B1 true BR9813279B1 (pt)	2010-11-16

Family

ID=27220661

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI9813279-2A BR9813279B1 (pt)	1997-10-27	1998-10-27	derivado de homopiperazina, composição farmacêutica, e, uso do derivado de homopiperazina.

Country Status (25)

Country	Link
US (2)	US6825189B1 (pt)
EP (2)	EP1027336B1 (pt)
JP (1)	JP4570773B2 (pt)
KR (1)	KR100607838B1 (pt)
CN (1)	CN1131211C (pt)
AT (2)	ATE278670T1 (pt)
AU (1)	AU744539B2 (pt)
BR (1)	BR9813279B1 (pt)
CA (1)	CA2306093C (pt)
CZ (1)	CZ299499B6 (pt)
DE (2)	DE69842058D1 (pt)
DK (1)	DK1027336T3 (pt)
EE (1)	EE04588B1 (pt)
ES (1)	ES2230723T3 (pt)
HU (1)	HU226859B1 (pt)
IL (2)	IL135108A0 (pt)
IS (1)	IS5420A (pt)
NO (1)	NO317094B1 (pt)
NZ (1)	NZ503520A (pt)
PL (1)	PL203140B1 (pt)
PT (1)	PT1027336E (pt)
RU (1)	RU2205179C2 (pt)
SK (1)	SK285198B6 (pt)
TR (1)	TR200001171T2 (pt)
WO (1)	WO1999021834A1 (pt)

Families Citing this family (65)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7214686B2 (en)	1997-06-30	2007-05-08	Targacept, Inc.	Pharmaceutical compositions and methods for effecting dopamine release
BR9813279B1 (pt) *	1997-10-27	2010-11-16		derivado de homopiperazina, composição farmacêutica, e, uso do derivado de homopiperazina.
EP1175416B1 (en)	1999-04-26	2003-07-16	Neurosearch A/S	Heteroaryl diazacycloalkanes, their preparation and use
EP1177196B1 (en)	1999-05-04	2004-03-10	Neurosearch A/S	Heteroaryl diazabicycloalkanes, their preparation and use
GB9914026D0 (en) *	1999-06-17	1999-08-18	Zeneca Ltd	Chemical compounds
ATE289607T1 (de)	1999-12-14	2005-03-15	Neurosearch As	Neue heteroaryl-diazabizykloalkane
US6809105B2 (en)	2000-04-27	2004-10-26	Abbott Laboratories	Diazabicyclic central nervous system active agents
MY145722A (en) *	2000-04-27	2012-03-30	Abbott Lab	Diazabicyclic central nervous system active agents
NZ524202A (en) *	2000-10-13	2004-08-27	Neurosearch As	Treatment of affective disorders by the combined action of a nicotinic receptor agonist and a monoaminergic substance
CA2341952A1 (en)	2001-03-23	2002-09-23	Universite Laval	Nicotinic receptor agonists for the treatment of inflammatory pulmonary diseases
US8557804B2 (en)	2002-03-25	2013-10-15	Universite Laval	Nicotinic receptor agonists for the treatment of inflammatory diseases
US8039459B2 (en)	2004-07-15	2011-10-18	Universite Laval	Nicotinic receptor agonists for the treatment of inflammatory diseases
BR0312414A (pt)	2002-07-05	2005-05-10	Targacept Inc	Compostos de n-aril diazaespirociclico e métodos para a preparação e uso dos mesmos
WO2004009775A2 (en)	2002-07-19	2004-01-29	Targacept, Inc.	Methods and compositions relating to chimeric nicotinic receptor subunits
US7098331B2 (en)	2003-03-05	2006-08-29	Targacept, Inc.	Arylvinylazacycloalkane compounds and methods of preparation and use thereof
GB0316915D0 (en)	2003-07-18	2003-08-20	Glaxo Group Ltd	Compounds
PT1678172E (pt)	2003-10-15	2010-03-03	Targacept Inc	Composições farmacêuticas e métodos para alívio da dor e tratamento de perturbações do sistema nervoso central
JP5254616B2 (ja)	2004-09-13	2013-08-07	クロノセラピューティクス、インコーポレイテッド	生物学的同調性（ｂｉｏｓｙｎｃｈｒｏｎｏｕｓ）経皮的薬物送達
CA2579820A1 (en)	2004-09-20	2006-03-30	Targacept, Inc.	Azaspiroalkene and azapiroalkane compounds with nicotinic cholinergic receptor activity
BRPI0515505A (pt)	2004-09-20	2008-07-29	Xenon Pharmaceuticals Inc	derivados heterocìclicos e sua utilização como inibidores da estearoil-coa desaturase
WO2006034341A2 (en)	2004-09-20	2006-03-30	Xenon Pharmaceuticals Inc.	Pyridazine derivatives for inhibiting human stearoyl-coa-desaturase
CA2580857A1 (en)	2004-09-20	2006-09-28	Xenon Pharmaceuticals Inc.	Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors
AU2005286728A1 (en)	2004-09-20	2006-03-30	Xenon Pharmaceuticals Inc.	Heterocyclic derivatives and their use as mediators of stearoyl-CoA desaturase
AU2005286648A1 (en)	2004-09-20	2006-03-30	Xenon Pharmaceuticals Inc.	Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitors
AU2005286653A1 (en) *	2004-09-20	2006-03-30	Xenon Pharmaceuticals Inc.	Pyridine derivatives for inhibiting human stearoyl-CoA-desaturase
MX2007003321A (es)	2004-09-20	2007-06-05	Xenon Pharmaceuticals Inc	Derivados heterociclicos y su uso como agentes terapeuticos.
AR051026A1 (es)	2004-09-20	2006-12-13	Xenon Pharmaceuticals Inc	Derivados heterociclicos y su uso como inhibidores de la estearoil-coa desaturasa
US7459469B2 (en)	2004-11-10	2008-12-02	Targacept, Inc.	Hydroxybenzoate salts of metanicotine compounds
UA88792C2 (ru)	2004-11-10	2009-11-25	Таргасепт, Інк.	Гидроксибензоатные соли метаникотиновых соединений
WO2006081332A1 (en) *	2005-01-25	2006-08-03	Epix Delaware, Inc.	Substituted arylamine compounds and their use as 5-ht6 modulators
FR2885616B1 (fr)	2005-05-12	2007-06-22	Servier Lab	Nouveaux derives de phenylpyridinylpiperazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2885615B1 (fr) *	2005-05-12	2007-06-22	Servier Lab	Nouveaux derives de phenylpyridinylpiperazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
MX2007015216A (es)	2005-06-03	2008-02-22	Xenon Pharmaceuticals Inc	Derivados de aminotiazol y sus usos como agentes terapeuticos.
FR2889188B1 (fr)	2005-07-28	2007-09-07	Servier Lab	Nouveaux composes 1,1-pyridinylaminocyclopropanamines polysubstitues, leur procede de preparation et les compositions phamaceutiques qui les contiennent
CN101248073A (zh)	2005-08-22	2008-08-20	塔加西普特公司	杂芳基-取代的二氮杂三环烷类、其制备方法及其应用
US20070134169A1 (en) *	2005-12-11	2007-06-14	Rabinoff Michael D	Methods for smoking cessation or alcohol cessation or other addiction cessation
TWI389889B (zh)	2006-05-09	2013-03-21	Targacept Inc	（２ｓ）-（４ｅ）-ｎ-甲基-５-〔３-（５-異丙氧基吡啶）基〕-４-戊烯-２-胺之新穎多晶型
EP2021325A2 (en)	2006-05-09	2009-02-11	AstraZeneca AB	Salt forms of (2s)-(4e)-n-methyl-5-[3-(5-isopropoxypyridin)yl]-4-penten-2-amine
WO2007137955A1 (en) *	2006-05-30	2007-12-06	F. Hoffmann-La Roche Ag	Piperidinyl pyrimidine derivatives
EP2255848A3 (en)	2006-09-04	2011-04-06	NeuroSearch AS	Pharmaceutical combinations of a nicotine receptor modulator and a cognitive enhancer
EP2322167A1 (en)	2007-04-02	2011-05-18	Parkinson's Institute	Methods and Compositions for Reduction of Side Effects of Therapeutic Treatments
EP2155689B1 (en)	2007-05-31	2015-07-08	Boehringer Ingelheim International GmbH	Ccr2 receptor antagonists and uses thereof
ATE503754T1 (de)	2007-10-01	2011-04-15	Comentis Inc	1h-indol-3-carbonsäure-chinuclidin-4- ylmethylesterderivate als liganden für den nikotinischen alpha-7-acetylcholinrezeptor zur behandlung von alzheimer-krankheit
US8697722B2 (en) *	2007-11-02	2014-04-15	Sri International	Nicotinic acetylcholine receptor modulators
EP2379525B1 (en)	2008-12-19	2015-07-29	Boehringer Ingelheim International GmbH	Cyclic pyrimidin-4-carboxamides as ccr2 receptor antagonists for treatment of inflammation, asthma and copd
CN102648202A (zh)	2009-12-07	2012-08-22	塔加西普特公司	作为神经元烟碱乙酰胆碱受体配体的3,6-二氮杂双环[3.1.1]庚烷
MX346393B (es)	2009-12-17	2017-03-17	Centrexion Therapeutics Corp	Nuevos antagonistas del receptor ccr2 y usos de los mismo.
CN102905527B (zh) *	2010-01-11	2016-08-24	阿斯特来亚治疗有限责任公司	烟碱型乙酰胆碱受体调节剂
EP2531500B1 (en)	2010-02-05	2018-01-24	Merck Patent GmbH	Hetaryl-[1,8]naphthyridine derivatives
US20110256064A1 (en) *	2010-04-16	2011-10-20	Ac Immune, S.A.	Novel Compounds for the Treatment of Diseases Associated with Amyloid or Amyloid-like Proteins
US8946218B2 (en)	2010-05-12	2015-02-03	Boehringer Ingelheim International Gmbh	CCR2 receptor antagonists, method for producing the same, and use thereof as medicaments
EP2569298B1 (en)	2010-05-12	2015-11-25	Boehringer Ingelheim International GmbH	Novel ccr2 receptor antagonists, method for producing the same, and use thereof as medicaments
US8841313B2 (en)	2010-05-17	2014-09-23	Boehringer Ingelheim International Gmbh	CCR2 antagonists and uses thereof
SG185497A1 (en)	2010-05-20	2012-12-28	Astrazeneca Ab	New process for the preparation of aryl substituted olefinic amines
WO2011147772A1 (en)	2010-05-25	2011-12-01	Boehringer Ingelheim International Gmbh	Ccr2 receptor antagonists
EP2576538B1 (en)	2010-06-01	2015-10-28	Boehringer Ingelheim International GmbH	New CCR2 antagonists
KR101281084B1 (ko) *	2011-02-01	2013-07-09	전북대학교산학협력단	양이온성을 지닌 생분해성 ｐａｏｘ 고분자 미립구
WO2013010839A1 (en)	2011-07-15	2013-01-24	Boehringer Ingelheim International Gmbh	Novel and selective ccr2 antagonists
CN102924390B (zh) *	2012-09-07	2014-12-31	苏州康润医药有限公司	1,5-二氮杂环辛烷-1-甲酸叔丁酯的合成方法
TW201617342A (zh)	2014-07-11	2016-05-16	阿法馬根公司	調節α７活性之啶類
CA2974324A1 (en)	2015-01-28	2016-08-04	Zita S. Netzel	Drug delivery methods and systems
BR112017028492B1 (pt)	2015-07-02	2023-12-26	Centrexion Therapeutics Corporation	Citrato de (4-((3r,4r)-3-metoxitetra-hidro-piran-4- ilamino)piperidin-1-il) (5- metil-6-(((2r, 6s)-6-(p-tolil) tetra-hidro-2h-piran-2-il)metilamino)pirimidin-4-il) metanona, seu uso e seu método de preparação, e composição farmacêutica
CA3049529A1 (en)	2017-01-06	2018-07-12	Chrono Therapeutics Inc.	Transdermal drug delivery devices and methods
JP7420797B2 (ja)	2018-05-29	2024-01-23	モーニングサイドベンチャーインベストメンツリミテッド	薬剤送達の方法及びシステム
EP3880175A4 (en)	2018-11-16	2022-08-17	Morningside Venture Investments Limited	TEMPERATURE-REGULATING TRANSDERMAL DRUG DELIVERY SYSTEM

Family Cites Families (51)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2985657A (en) *	1959-10-12	1961-05-23	Paul A J Janssen	1-(aroylalkyl)-4-heterocyclylpiperazines
JPS4966691A (pt) *	1972-10-30	1974-06-27
US4017622A (en)	1972-12-18	1977-04-12	Dainippon Pharmaceutical Co., Ltd.	Piperazine derivatives
AT330777B (de)	1973-09-08	1976-07-26	Thomae Gmbh Dr K	Verfahren zur herstellung von neuen isochinolinderivaten und deren salzen
EG12387A (en) *	1975-04-21	1978-12-31	Merck & Co Inc	Process for preparing of piperazinyl pyrazines
US3994898A (en) *	1975-10-16	1976-11-30	E. R. Squibb & Sons, Inc.	1,2,4-Triazolo (4,3-b) pyridazin-3-ones
NL171985C (nl) *	1976-02-10	1983-06-16	Rhone Poulenc Ind	Werkwijze voor het bereiden van preparaten met werking tegen schistosomiasis, de aldus verkregen gevormde preparaten en werkwijze voor het bereiden van 1,2-dithioolverbindingen.
GB1542030A (en) *	1976-08-19	1979-03-14	Sterling Drug Inc	Cyclic alkylidenyl n-(pyridazinyl)aminomethylenemalomates and their preparation
DE2708187A1 (de) *	1977-02-25	1978-08-31	Thomae Gmbh Dr K	Neue pyrido-pyridazin-one
HU176972B (hu) *	1977-06-13	1981-06-28	Gyogyszerkutato Intezet	Sposob poluchenija novykh proizvodnykh piridazinil-gidrazona
US4163849A (en) *	1978-03-17	1979-08-07	Merck & Co., Inc.	Piperazinylpyrazines
US4179563A (en) *	1978-05-19	1979-12-18	Warner-Lambert Company	3-Aryloxy-substituted-aminopyridines and methods for their production
JPS5618983A (en) *	1979-07-25	1981-02-23	Eisai Co Ltd	Theophylline derivative and its preapration
US4251530A (en)	1980-02-19	1981-02-17	Merck & Co., Inc.	2-{[4-(6-Substituted-2-pyrazinyl)-1-piperazinyl]alkyl}-5-substituted-1,2,4-triazolo[4,3-a]pyridin-3(2H)-one analgesic agents
DE3034001A1 (de) *	1980-09-10	1982-04-22	Hoechst Ag, 6000 Frankfurt	Isochinolinderivate, verfahren zu ihrer hersellung, sie enthaltende pharmazeutische zubereitungen und ihre verwendung
FI70411C (fi) *	1980-12-29	1986-09-19	Pfizer	Foerfarande foer framstaellning av nya antihypertensiva 4-amino-6,7-dimetoxi-2-piperazinokinazolin derivat
US5001125A (en) *	1984-03-26	1991-03-19	Janssen Pharmaceutica N.V.	Anti-virally active pyridazinamines
PL147465B1 (en) *	1984-03-26	1989-06-30	Janssen Pharmaceutica Nv	Method of obtaining novel pyridazionoamine compounds
ES8802151A1 (es) *	1985-07-31	1988-04-01	Janssen Pharmaceutica Nv	Un procedimiento para la preparacion de nuevos piridazinaminas.
GB8603120D0 (en) *	1986-02-07	1986-03-12	Pfizer Ltd	Anti-dysrhythmia agents
GB8609630D0 (en) *	1986-04-19	1986-05-21	Pfizer Ltd	Anti-arrhythmia agents
SE8701375D0 (sv)	1987-04-02	1987-04-02	Leo Ab	Novel pyridyl- and pyrimidyl derivatives
MY104343A (en) *	1987-11-23	1994-03-31	Janssen Pharmaceutica Nv	Novel pyridizinamine deravatives
US4876256A (en)	1988-04-29	1989-10-24	Merck & Co., Inc.	Alkylpiperazinylpyridines as hypoglycemic agents
SE8803429D0 (sv)	1988-09-28	1988-09-28	Pharmacia Ab	Novel pyridyl- and pyrimidyl derivatives
EP0361489A3 (en) *	1988-09-30	1991-06-12	Chugai Seiyaku Kabushiki Kaisha	Novel 3,4-diaminoquinoline and pyridine compounds
JPH02167265A (ja) *	1988-09-30	1990-06-27	Chugai Pharmaceut Co Ltd	新規な３，４―ジアミノキノリン及びピリジン系化合物
IE62792B1 (en)	1988-11-24	1995-03-08	Akzo Nv	Pharmaceutical composition containing 1-(mono- or bis (Trifluoromethyl)-2-pyridinyl) piperazines
JP2843632B2 (ja) *	1989-03-01	1999-01-06	日清製粉株式会社	ピリジンカルボン酸アミド誘導体
US4994456A (en) *	1989-03-01	1991-02-19	Nisshin Flour Milling Co., Ltd.	Pyridinecarboxylic acid amide derivatives and pharmaceutical compositions comprising same
NZ233526A (en) *	1989-05-15	1991-09-25	Janssen Pharmaceutica Nv	Pyridazine derivatives and their pharmaceutical compositions
WO1991009849A1 (en) *	1989-12-28	1991-07-11	The Upjohn Company	Diaromatic substituted anti-aids compounds
ES2097341T3 (es) *	1991-07-03	1997-04-01	Upjohn Co	Indoles sustituidos como farmacos para el tratamiento del sida.
JPH05345764A (ja) *	1991-11-26	1993-12-27	Asahi Chem Ind Co Ltd	新規アゼピン誘導体、その製造法およびその用途
SE9201239D0 (sv)	1992-04-21	1992-04-21	Kabi Pharmacia Ab	Agents for treating substance abuse disorders
TW279864B (pt) *	1993-02-19	1996-07-01	Janssen Pharmaceutica Nv
EP0690713A4 (en) *	1993-03-17	1996-04-03	Abbott Lab	SUBSTITUTED MACROCYCLIC IMMUNOMODULATORS CONTAINING ALICYCLIC AMINES
GB9408185D0 (en) *	1994-04-25	1994-06-15	Fujisawa Pharmaceutical Co	New benzamide derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same
US5607936A (en) *	1994-09-30	1997-03-04	Merck & Co., Inc.	Substituted aryl piperazines as neurokinin antagonists
EP0793662A1 (en)	1994-11-23	1997-09-10	Neurogen Corporation	Aminomethyl aryl compounds; dopamine receptor subtype selective ligands
ES2162235T3 (es) *	1996-01-15	2001-12-16	Janssen Pharmaceutica Nv	Piridazinaminas inhibidoras de la angiogenesis.
US5929281A (en) *	1996-04-19	1999-07-27	Tosoh Corporation	Process for producing heterocyclic aromatic amine or arylamine
SE9601708D0 (sv)	1996-05-06	1996-05-06	Pharmacia Ab	Pyridyl- and pyrimidyl-piperazines in the treatment of substance abuse disorders
GB9614236D0 (en)	1996-07-06	1996-09-04	Zeneca Ltd	Chemical compounds
JP3216566B2 (ja) *	1996-07-15	2001-10-09	東ソー株式会社	複素環式芳香族アミン類の製造方法
WO1998031679A1 (en) *	1997-01-21	1998-07-23	Yoshitomi Pharmaceutical Industries, Ltd.	Thiophene compounds and medicinal use thereof
DE19724980A1 (de) *	1997-06-13	1998-12-17	Basf Ag	3-Substituierte 3,4-Dihydro-thieno[2,3-d]pyrimidin-Derivate, ihre Herstellung und Verwendung
AU8457298A (en) *	1997-08-15	1999-03-08	Pfizer Products Inc.	2-(4-aryl or heteroaryl-piperazin-1-ylmethyl)-1H-indole derivatives interacting with the dopamine D4 receptor
JP3329337B2 (ja) *	1997-10-14	2002-09-30	三菱ウェルファーマ株式会社	ピペラジン化合物およびその医薬としての用途
BR9813279B1 (pt) *	1997-10-27	2010-11-16		derivado de homopiperazina, composição farmacêutica, e, uso do derivado de homopiperazina.
GB9726736D0 (en)	1997-12-18	1998-02-18	Zeneca Ltd	Chemical compounds

1998
- 1998-10-27 BR BRPI9813279-2A patent/BR9813279B1/pt not_active IP Right Cessation
- 1998-10-27 AU AU97368/98A patent/AU744539B2/en not_active Ceased
- 1998-10-27 CA CA2306093A patent/CA2306093C/en not_active Expired - Fee Related
- 1998-10-27 EP EP98951286A patent/EP1027336B1/en not_active Expired - Lifetime
- 1998-10-27 WO PCT/DK1998/000465 patent/WO1999021834A1/en not_active Ceased
- 1998-10-27 CZ CZ20001507A patent/CZ299499B6/cs not_active IP Right Cessation
- 1998-10-27 AT AT98951286T patent/ATE278670T1/de active
- 1998-10-27 DE DE69842058T patent/DE69842058D1/de not_active Expired - Lifetime
- 1998-10-27 EP EP04102866A patent/EP1491532B1/en not_active Expired - Lifetime
- 1998-10-27 PL PL340224A patent/PL203140B1/pl not_active IP Right Cessation
- 1998-10-27 TR TR2000/01171T patent/TR200001171T2/xx unknown
- 1998-10-27 CN CN98810601A patent/CN1131211C/zh not_active Expired - Fee Related
- 1998-10-27 ES ES98951286T patent/ES2230723T3/es not_active Expired - Lifetime
- 1998-10-27 EE EEP200000178A patent/EE04588B1/xx not_active IP Right Cessation
- 1998-10-27 AT AT04102866T patent/ATE491689T1/de not_active IP Right Cessation
- 1998-10-27 JP JP2000517946A patent/JP4570773B2/ja not_active Expired - Fee Related
- 1998-10-27 RU RU2000110744/04A patent/RU2205179C2/ru not_active IP Right Cessation
- 1998-10-27 PT PT98951286T patent/PT1027336E/pt unknown
- 1998-10-27 IL IL13510898A patent/IL135108A0/xx active IP Right Grant
- 1998-10-27 DE DE69826883T patent/DE69826883T2/de not_active Expired - Lifetime
- 1998-10-27 NZ NZ503520A patent/NZ503520A/xx unknown
- 1998-10-27 HU HU0100426A patent/HU226859B1/hu not_active IP Right Cessation
- 1998-10-27 DK DK98951286T patent/DK1027336T3/da active
- 1998-10-27 KR KR1020007004495A patent/KR100607838B1/ko not_active Expired - Fee Related
- 1998-10-27 SK SK614-2000A patent/SK285198B6/sk not_active IP Right Cessation
2000
- 2000-03-16 IL IL135108A patent/IL135108A/en not_active IP Right Cessation
- 2000-03-17 US US09/528,176 patent/US6825189B1/en not_active Expired - Fee Related
- 2000-03-28 IS IS5420A patent/IS5420A/is unknown
- 2000-04-26 NO NO20002132A patent/NO317094B1/no not_active IP Right Cessation
2003
- 2003-10-03 US US10/677,240 patent/US6897219B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
BR9813279A (pt)	2000-08-22
CZ20001507A3 (cs)	2000-08-16
NO20002132L (no)	2000-04-26
EE04588B1 (et)	2006-02-15
EP1027336B1 (en)	2004-10-06
SK285198B6 (sk)	2006-08-03
AU9736898A (en)	1999-05-17
EP1027336A1 (en)	2000-08-16
HU226859B1 (en)	2009-12-28
ES2230723T3 (es)	2005-05-01
IS5420A (is)	2000-03-28
WO1999021834A1 (en)	1999-05-06
EE200000178A (et)	2001-04-16
IL135108A (en)	2006-12-31
KR20010031461A (ko)	2001-04-16
DE69842058D1 (de)	2011-01-27
DE69826883D1 (de)	2004-11-11
HUP0100426A2 (hu)	2002-02-28
PL203140B1 (pl)	2009-08-31
KR100607838B1 (ko)	2006-08-04
AU744539B2 (en)	2002-02-28
ATE491689T1 (de)	2011-01-15
NO20002132D0 (no)	2000-04-26
US6897219B2 (en)	2005-05-24
ATE278670T1 (de)	2004-10-15
PL340224A1 (en)	2001-01-15
TR200001171T2 (tr)	2000-10-23
CN1277604A (zh)	2000-12-20
CN1131211C (zh)	2003-12-17
CA2306093A1 (en)	1999-05-06
HUP0100426A3 (en)	2002-03-28
JP4570773B2 (ja)	2010-10-27
EP1491532B1 (en)	2010-12-15
DK1027336T3 (da)	2005-01-24
IL135108A0 (en)	2001-05-20
DE69826883T2 (de)	2005-02-03
HK1031378A1 (en)	2001-06-15
NZ503520A (en)	2002-08-28
EP1491532A1 (en)	2004-12-29
PT1027336E (pt)	2005-01-31
SK6142000A3 (en)	2000-09-12
RU2205179C2 (ru)	2003-05-27
US6825189B1 (en)	2004-11-30
NO317094B1 (no)	2004-08-09
CA2306093C (en)	2011-01-04
CZ299499B6 (cs)	2008-08-13
JP2001521025A (ja)	2001-11-06
US20040072823A1 (en)	2004-04-15

Publication	Publication Date	Title
BR9813279B1 (pt)	2010-11-16	derivado de homopiperazina, composição farmacêutica, e, uso do derivado de homopiperazina.
TR199801594A2 (xx)	1999-03-22	CCR-3 resept�r antagonistleri.
ES2162676T3 (es)	2002-01-01	Derivados de fenileno sustituidos en meta y su uso como antagonistas o inhibidores de integrina alfav,beta3.
HUP9802036A3 (en)	1999-06-28	Novel substituted piperazine derivatives having tachykinin receptor antagonists activity, process for producing them an pharmaceutical compositions containing them
IL119729A0 (en)	1997-03-18	Heterocyclic compounds having tachykinin receptor antagonist activity pharmaceutical compositions containing the same and processes for the preparation thereof
BR0205829A (pt)	2005-03-08	Novas aminas como ligantes dos receptores de histamina-3 e suas aplicações terapêuticas
DE69837346D1 (de)	2007-04-26	Anilidderivate, deren herstellung und verwendung
CA2523261A1 (en)	2004-11-18	Fused pyrimidine derivatives with crf activity
ZA984637B (en)	1998-12-21	Spiro-quinuclidine derivatives their preparation and use
YU53100A (sh)	2003-04-30	Derivati 2-ariletil-(piperidin-4-ilmetil)amina kao antagonisti muskarinskih receptora
BR0310077A (pt)	2005-02-22	Novos compostos e sua utilização
ATE527247T1 (de)	2011-10-15	Benzokondensierte 5gliedrige heterocyclische verbindungen, verfahren zu deren herstellung und deren verwendung
DE69622246D1 (de)	2002-08-14	Neue Naphthamid-Derivate und ihre therapeutische Verwendung als D3-Rezeptor Agonisten
HUP9801950A2 (hu)	1999-03-29	2-(Aril-fenil-amino)-imidazolin-származékok, eljárás előállításukra és ezeket tartalmazó gyógyszerkészítmények
AR004669A1 (es)	1999-03-10	Nuevos derivados de la n[(1,4-diazabiciclo[2.2.2]oct-2-il)metil]benzamida, procedimiento para prepararlos y los medicamentos y las composicionesfarmaceuticas que los contienen.
ES519854A0 (es)	1984-03-16	Un procedimiento para la preparacion de 1-(3-halo-2-piridinil) piperazinas.
FI963440A0 (fi)	1996-09-03	Uudet aminohappojohdannaiset, näiden valmistusmenetelmä ja näitä yhdisteitä sisältävät farmaseuttiset seokset
ATE311384T1 (de)	2005-12-15	Eine amidgruppe tragende schwefelhaltige verbindungen, verfahren zu ihrer herstellung, deren verwendung in medikamenten und sie enthaltende pharmazeutische zubereitungen
KR880001587A (ko)	1988-04-25	[2-디메틸아미노에틸][2-[2-(메틸티오)페닐](페닐메틸)아미노]-2-옥소에틸]카바메이트 또는 요소, 그의 제법 및 치료에의 응용
BRPI0409957A (pt)	2006-04-25	imidazolin-2-ilaminofenil amidas
PL321545A1 (en)	1997-12-08	Substituted phenyl compounds and method of applying them as endoteline antagonists
BR9705064A (pt)	1999-07-20	Compostos de benzopirano processo para a preparação dos mesmos e composições farmacéuticas contendo os mesmos
ES2175337T3 (es)	2002-11-16	Compuesto bifenilicos y su utilizacion como agentes estrogenicos.
FR2777780B1 (fr)	2001-05-04	Derives d'(alpha-aminophosphino) peptides, leur procede de preparation et les compositions qui les contiennent
FI932206A7 (fi)	1993-05-14	Uusia heterosyklisiä yhdisteitä ekskitatoristen aminohapporeseptorien antagonisteina, menetelmä niiden valmistamiseksi ja niiden käyttö

Legal Events

Date	Code	Title	Description
2007-09-04	B07A	Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
2008-10-07	B06A	Patent application procedure suspended [chapter 6.1 patent gazette]
2010-02-17	B09A	Decision: intention to grant [chapter 9.1 patent gazette]
2010-11-16	B16A	Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]	Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 16/11/2010, OBSERVADAS AS CONDICOES LEGAIS.
2014-04-08	B24H	Lapse because of non-payment of annual fees (definitively: art 78 iv lpi)
2020-12-01	B24F	Patent annual fee: publication cancelled	Free format text: ANULADA A PUBLICACAO CODIGO 24.8 NA RPI NO 2257 DE 08/04/2014 POR TER SIDO INDEVIDA.
2020-12-15	B21F	Lapse acc. art. 78, item iv - on non-payment of the annual fees in time	Free format text: REFERENTE AS 14A, 15A, 16A, 17A, 18A, 19A, 20A, 21A E 22A ANUIDADES.
2021-04-13	B24J	Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)	Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2606 DE 15-12-2020 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.